Spotlight Medical
1 known investors
Find your way into Spotlight Medical
417 people in our graph share verified history with the Spotlight Medical team — schools, employers, funds. One of them is your warm intro.
Vincent Diallounlockedknows Sylvain Berlemont · together at StartX
×3knows the team · via Université Paris Cité
×8knows the team · via StartX
Spotlight Medical develops AI-enabled prognostic assays for cancer risk assessment, starting with myStage Dx, a test for early-stage ER+/HER2– breast cancer that helps clinicians identify low-risk patients within high-risk clinical groups. The assay analyzes routine pathology slides using machine learning to generate personalized relapse risk scores.
Founders & leadership
SB
Sylvain BerlemontinCofounder & Chief Executive OfficerSylvain Berlemont is cofounder and CEO of Spotlight Medical, which develops AI-enabled prognostic assays for cancer risk assessment.
ML
Marvin LerousseauinCofounder & Chief Scientific Officer
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeed FundingJul 2024 · 4 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Spotlight Medical do?
- Spotlight Medical develops AI-enabled prognostic assays for cancer risk assessment, starting with myStage Dx, a test for early-stage ER+/HER2– breast cancer that helps clinicians identify low-risk patients within high-risk clinical groups. The assay analyzes routine pathology slides using machine learning to generate personalized relapse risk scores.
- Who founded Spotlight Medical?
- Spotlight Medical was founded by Sylvain Berlemont, Marvin Lerousseau.
- Who are Spotlight Medical's investors?
- Spotlight Medical's investors include Heal Capital.